Tat transport of a Sec passenger leads to both completely translocated as well as membrane-arrested passenger proteins  by Dittmar, Julia et al.
Biochimica et Biophysica Acta 1843 (2014) 446–453
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbamcrTat transport of a Sec passenger leads to both completely translocated
as well as membrane-arrested passenger proteinsJulia Dittmar, René Schlesier, Ralf Bernd Klösgen ⁎
Institute of Biology—Plant Physiology, Martin-Luther-University Halle-Wittenberg, Weinbergweg 10, 06120 Halle/Saale, GermanyAbbreviations: Tat, twin-arginine translocation; Sec, s
intermediate-1(-2); TPP, thylakoidal processing peptidase
subunit of the oxygen-evolving system associated with ph
OEC33; preOEC33, precursor OEC33; PAGE, polyacrylamid
⁎ Corresponding author. Tel.: +49 345 55 26 200; fax:
E-mail address: klosgen@pﬂanzenphys.uni-halle.de (R
0167-4889/$ – see front matter © 2013 Elsevier B.V. All r
http://dx.doi.org/10.1016/j.bbamcr.2013.11.025a b s t r a c ta r t i c l e i n f oArticle history:
Received 10 October 2013
Received in revised form 26 November 2013
Accepted 29 November 2013
Available online 7 December 2013
Keywords:
Protein transport
Twin-arginine translocation
Thylakoid membrane
Tat pathway
Stop-transfer
Membrane arrestWe have studied the membrane transport of the chimeric precursor protein 16/33, which is composed of the
Tat1-speciﬁc transport signal of OEC16 and the Sec passenger protein OEC33, both subunits of the oxygen-
evolving system associated with photosystem II. Protein transport experiments performed with isolated pea
thylakoids show that the 16/33 chimera is transported in a strictly Tat-dependent manner into the thylakoid
vesicles yieldingmature OEC33 (mOEC33) in two different topologies. One fraction accumulates in the thylakoid
lumen and is thus resistant to externally added protease. A second fraction is arrested during transport in
an N-in/C-out topology within the membrane. Chase experiments demonstrate that this membrane-
arrested mOEC33 moiety does not represent a translocation intermediate but instead an alternative
end product of the transport process. Transport arrest of mOEC33, which is embedded in the membrane with
a mildly hydrophobic protein segment, requires more than 26 additional and predominantly hydrophilic
residues C-terminal of the membrane-embedded segment. Furthermore, it is stimulated by mutations which
potentially affect the conformation of mOEC33 suggesting that at least partial folding of the passenger protein
is required for complete membrane translocation.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Two independent transport routes, called secretory (Sec) and twin
arginine translocation (Tat) pathway, are responsible for translocating
hydrophilic proteins across the thylakoid membrane of chloroplasts
as well as the plasma membranes of bacteria and archaea. They are
speciﬁcally engaged by signal peptides present in the N-terminal
regions of the transport substrates that are distinguished from each
other primarily by the type of positively charged residue found up-
stream of the hydrophobic core segment. While in Sec signal peptides
a single lysine residue is usually present, Tat signal peptides almost
invariantly carry a twin pair of arginine residues at this position coining
even the name of the pathway [1–3]. The two pathways operate with
different mechanisms and distinct transport machineries (for recent
reviews see [4–8]). Protein transport by the Sec pathway requires ATP
and the presence of both integral (SecY, SecE) and soluble (SecA) com-
ponents of the transport apparatus. In contrast, the Tat pathway is
energised solely by a membrane potential, notably ΔpH and/or ΔΨ
[9,10], and can operate independently from any soluble compound.ecretory; Ti-1(-2), translocation
; OEC16 (23,33), 16 (23,33) kDa
otosystem II; mOEC33, mature
e gel electrophoresis
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.B. Klösgen).
ights reserved.Tat machinery consists of the three integral membrane proteins TatA,
TatB, and TatC (in the thylakoid system also called Tha4, Hcf106, and
cpTatC, respectively), although catalytically active TatA has additionally
been detected soluble in the chloroplast stroma [11].
As most other protein transport pathways, the Sec pathway
translocates polypeptide chains in an unfolded conformation across
the membrane. In contrast, the Tat pathway is capable of transporting
proteins in a fully folded, or even malfolded, conformation across ion-
tightmembranes [3,12–15]. This permits the incorporation of prosthetic
groups or cofactors, like iron–sulphur clusters or molybdopterin, into
the respective apoproteins prior to the ﬁnal membrane translocation
step [13,16,17] which might have been the fundamental cause for the
development and evolutionary persistence of this transport route.
Even transport of two independently folded proteins by a single Tat
transport signal has been described [18,19] which reinforces the
competence of Tat machinery to handle complex substrates. On the
other hand, passenger proteins that are not properly folded are often
precluded from Tat-dependent membrane translocation [20–22]
which led to the suggestion that a kind of “quality control”mechanism
exists that prevents the Tat machinery from being compromised by
transport-incompetent substrates [23–25]. How the discrimination
between different substrate conformations is achieved remains unclear,
since the mechanism of Tat translocation is still unknown.
Tat transport is initiated by binding of the substrate precursor
protein to the integral TatBC receptor complex [19,21,26–28], which
in plants has a size of approximately 560–700 kDa. Subsequent mem-
brane translocation of the passenger polypeptide, which requires both
447J. Dittmar et al. / Biochimica et Biophysica Acta 1843 (2014) 446–453TatA and the membrane potential, is still a matter of debate. Three
deviating working models are currently discussed: (a) translocation
poreswith a different or variable diameter to facilitatemembrane trans-
port of the various Tat substrates, which are all distinct in size [29–31],
(b) TatA-induced membrane weakening resulting in translocation of
the substrate directly through the lipid bilayer [32], and (c) a catalytic
or regulatory function of TatA facilitating membrane transport by the
TatBC complexes [28,33].
Here,we have asked thequestion if OEC33, the 33 kDa subunit of the
oxygen-evolving system associated with photosystem II (gene: psbO),
which in combination with its authentic transit peptide is a well-
characterised model substrate of the thylakoidal Sec machinery
[34–36], can be successfully transported also by the Tat pathway across
the thylakoid membrane. The Tat-speciﬁc transport signal required for
this purpose is provided by the transit peptide of OEC16, the 16 kDa
subunit of the oxygen-evolving system (gene: psbQ), which is a suitable
transport signal also for heterologous passengers like the green
ﬂuorescent protein [37]. Our experiments show that the thylakoidal
Tat machinery is indeed able to translocate the OEC33 passenger across
the membrane. However, only a subset of proteins is fully translocated
into the thylakoid lumen, while the rest is arrested in the membrane
in an N-in/C-out topology.2. Materials and methods
2.1. Cloning and mutagenesis
Generation of the cDNA clone encoding the chimeric 16/33
precursor protein, which is composed of the transit peptide of OEC16
and mature OEC33, both subunits of the oxygen-evolving system
associated with photosystem II from spinach, is described in [38].
Mutagenesis was carried out with the QuikChange® Site-Directed
Mutagenesis Kit (Stratagene, La Jolla, CA, USA) using the primers listed
in Table S1 and conﬁrmed by DNA sequencing.2.2. In thylakoido protein transport experiments
Isolation of chloroplasts and thylakoids from pea seedlings (Pisum
sativum var. Feltham First) was carried out according to [39]. Stromal
extract was prepared as described in [11] omitting though the ultra-
centrifugation step. This initial extract was subsequently concentrated
10-fold using Vivaspin 3.000 MWCO PES ultraﬁltration columns
(Sartorius AG, Göttingen, Germany) to approximate the stromal
concentration present within intact chloroplasts. In thylakoido protein
transport experiments with radiolabelled precursor proteins followed
published protocols [37] and were performed in the absence of stromal
extract if not otherwise indicated. Modiﬁcations like anti-TatA treat-
ment of thylakoids and supplementation of the assayswith puriﬁed, sol-
uble TatA were carried out following the protocols of [33]. Protease
treatment of the transport assays was performed as described in [40]
using protease concentrations of 200 μg/ml (thermolysin), 3 μg/ml
(trypsin), and 50 μg/ml (proteinase K). Proteolysis was terminated by
supplementing the assayswith 10 mMEDTA, 50 μg/ml trypsin inhibitor
from bovine pancreas, and 10 mM PMSF, respectively.2.3. Miscellaneous
Gel electrophoresis of proteins under denaturing conditions was
performed according to [41]. The gels were exposed to phosphorimager
screens and analysed with the Fujiﬁlm FLA-3000 (Fujiﬁlm, Düsseldorf,
Germany) using the software packages BAS-Reader (version 3.14) and
AIDA (version 3.25; Raytest, Straubenhardt, Germany). All othermethods
followed published protocols [42].3. Results
3.1. Thylakoidal Tat transport of the chimeric 16/33 protein yields two
products of identical size but different localisation
The precursor of the 33 kDa subunit of the oxygen-evolving system
associatedwith photosystem II (preOEC33) carries a typical Sec-speciﬁc
signal peptide mediating its transport by the Sec pathway across the
thylakoidmembrane. Consequently, transport of preOEC33 into isolated
thylakoids is achieved only with vesicles that are resuspended in stro-
mal extracts conﬁrming the need of stromal components like SecA. In
such assays, accumulation of the mature protein (mOEC33) is observed
(Fig. 1A) as a result of removal of the transport signal by thylakoidal
processing peptidase, TPP, which exerts its activity on the lumenal
side of the membrane [43]. Furthermore, mOEC33 is resistant to exter-
nally added protease (Fig. 1A) demonstrating that it was completely
translocated across themembrane into the thylakoid lumen. In contrast,
if the thylakoids are resuspended in HM buffer rather than in stromal
extracts, neither transport nor processing of preOEC33 takes place and
the protein remains fully accessible to externally added protease.
However, when fused to the transit peptide of the 16 kDa subunit of
the oxygen-evolving system (OEC16), which comprises a Tat-speciﬁc
signal peptide, mOEC33 can be transported across the thylakoid mem-
brane both in the presence and absence of stromal extract (Fig. 1A)
demonstrating that stromal factors are neither necessary nor inhibitory
formembrane translocation. In linewith the presence of a potential Sec-
avoidance motif [44] in the C-terminal region of the OEC16 transit
peptide (Fig. 2B), thylakoid transport of this 16/33 chimera takes place
exclusively by the Tat pathway and is thus prevented after treatment
of thylakoid vesicles with afﬁnity-puriﬁed anti-TatA antibodies to
block intrinsic TatA activity (Fig. 1B). Supplementation of such assays
with puriﬁed soluble TatA as described in [33] leads to complete
reconstitution of thylakoid transport resulting in the accumulation
of mOEC33 in the thylakoid lumen where it is protected against prote-
olysis by externally added proteases like thermolysin (Fig. 1B).
In addition to mOEC33, a degradation product of approximately
15 kDa is found in thermolysin-treated thylakoids after transport of
the 16/33 chimera (Fig. 1A and B). Its occurrence depends on a function-
al Tat machinery, since no such degradation product is observed in
transport assays comprising anti-TatA treated thylakoids and reconsti-
tution of Tat transport by soluble TatA leads to its recurrence. Degrada-
tion products of similar size are obtained when thermolysin is replaced
by either of the proteases trypsin or proteinase K (Fig. 1C). In contrast,
control treatment of the 16/33 in vitro translation product with these
proteases in the absence of thylakoid vesicles (Fig. 1C, lanes t+)
leads either to complete degradation (thermolysin, proteinase K) or to
a product of approximately 24 kDa (trypsin) demonstrating that the
15 kDa fragment is not caused by a protease insensitive domain within
the 16/33 chimera. Remarkably, the accumulation of the 15 kDa frag-
ment is accompanied by the concomitant decrease in signal intensity
for mOEC33. Irrespective of the protease used, usually 30%–40% of
mOEC33 accumulating in the thylakoids after transport of the 16/33 chi-
mera is fully resistant to external proteolysis (Fig. 1C) demonstrating
that only a fraction of the mature protein moiety is in fact situated in
the thylakoid lumen. An even larger proportion of mOEC33 assumes
instead a topology within the membrane which allows limited access
from the stromal side.
3.2. The protease-protected fragment does not represent a
translocation intermediate
Protected polypeptide fragments obtained upon protease treatment
of protein transport assays are often indicative of translocation interme-
diates. Typical examples are the two consecutive translocation interme-
diates, Ti-1 and Ti-2, described earlier for the chimeric precursor protein
16/23, which carries the transit peptide of OEC16 fused to mature
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and can be converted to mOEC23 at extended incubation times
(e.g., [33,39,45]). In contrast, the amount of protease-protected
15 kDa fragment obtained after thylakoid transport of the 16/33
chimera increases in intensity when transport is performed for longer
time periods (Fig. 3A). Furthermore, we could not observe any chase
into protease-protected mOEC33 with time (Fig. 3B), not even by
supplementing the assays with excess amounts of TatA (Fig. S1).
Hence, the 15 kDa fragment apparently represents an alternative end
product of the Tat-dependent translocation process rather than a trans-
location intermediate.
Accumulation of the 15 kDa fragment in protease-treated thylakoids
is accompanied by the concomitant decline in the amount of mOEC33
(e.g., Fig. 1C). In order to examine if the 15 kDa fragment results from
proteolytic degradation of the 16/33 precursor or of mOEC33, thylakoid
transport experiments were performed with 16[tpp]/33, a mutant
derivative of the 16/33 precursor protein carrying an inactive cleavage
site for TPP (Fig. 2A). In line with earlier work analysing a comparable
mutant precursor [19], this 16[tpp]/33 chimera is not processed by
TPP upon incubation with isolated thylakoids and solely the precursorprotein can be detected in such transport assays (Fig. 4A). Thylakoid
transport of this mutant is demonstrated by the accumulation of two
protease-protected fragments after thermolysin treatment of the thyla-
koids (Fig. 4A). The apparent molecular weights of these two fragments
(30 kDa and 18 kDa) are each approximately 3 kDa higher than those
of mOEC33 (27 kDa) and the 15 kDa fragment, respectively, which are
observed after transport of the “original” 16/33 chimera. Considering
that 3 kDa is almost exactly the size of the C-terminal segment of the
signal peptide that upon Tat transport is embedded in the thylakoid
membrane and thus protected against proteolysis [46], the 18 kDa frag-
ment presumably represents the 15 kDa fragment carrying still a part of
the signal peptide (Fig. 4B). Taken together, these ﬁndings suggest that
the protease-protected 15 kDa fragment obtained upon thylakoid
translocation of the 16/33 chimera does not comprise parts of the trans-
port signal. Instead, it represents mOEC33 that has not completely
crossed the thylakoid membrane. In turn, this implies that processing
of a Tat substrate by TPP can occur before membrane translocation has
been completed.
3.3. Mapping of the membrane-embedded mOEC33 moiety
The primary sequence of the 16/33 chimera contains ﬁve methio-
nine residues in the transit peptide but only a singlemethionine residue
at position 78 within mOEC33 (Fig. 2B). The latter must also be
contained in the protease-protected 15 kDa fragment, which otherwise
would not be detectable by autoradiography after transport of the [35S]-
methionine labelled 16/33 chimera. Furthermore, the position of this
methionine residue provides initial information regarding the topology
of the membrane-embedded mOEC33 moiety. Its N-terminus must
have reached the lumenal side of the thylakoid membrane, since other-
wise processing of the precursor by TPP could not have taken place [43],
while the C-terminal border of the protease-protected fragment must
be situated downstream of position 78 of mOEC33 to preserve the
radiolabelled residue.
To map the C-terminal border of the 15 kDa fragment more
precisely systematic cysteine scanning experiments were performed.
In such experiments, selected codons within the coding sequence of
the candidate protein are individually replaced by codons for cysteine,
which subsequently can be utilised for radioactive labelling by in vitroFig. 1. Thylakoid transport of the 16/33 chimera leads to two products of different
membrane topology. (A) Thylakoid transport of the mOEC33 passenger protein by Sec-
and Tat-dependent transport signals. The authentic precursor protein of OEC33 (named
preOEC33 or 33/33, left panel) and the chimeric precursor protein 16/33 (right panel)
were obtained by in vitro transcription/translation of the corresponding cDNA clones in
the presence of [35S]-methionine. 5 μl of the translation assayswere incubatedwith isolat-
ed pea thylakoids that had been resuspended either in HM buffer (10 mM Hepes/KOH,
pH 8.0; 5 mM MgCl2) (HM) or in stromal extract of pea (stroma). After incubation for
15 min at 25 °C in the light, thylakoids were washed with HM buffer and either treated
with thermolysin (200 μg/ml, 30 minon ice, lanes+)ormock-treated (lanes−). Stoichio-
metric amounts of each fraction corresponding to 15 μg of chlorophyll were separated on
10–17.5% SDS-polyacrylamide gradient gels and visualised by phosphorimaging. In lanes t,
1 μl of the respective translation assay was loaded. The precursor (p) andmature proteins
(m) are indicated by ﬁlled arrowheads, while the open arrowhead points to the position of
the protease-protected fragment (f) observed uponmembrane transport of the 16/33 chi-
mera. The molecular weights (in kDa) of marker proteins loaded in parallel are indicated
on the left. (B) Thylakoid transport of the 16/33 chimera takes place by the Tat pathway.
In thylakoido assays containing anti-TatA treated thylakoids were supplemented with
either 2 μM puriﬁed TatA from Arabidopsis thaliana (TatA), which was obtained by
heterologous overexpression in E. coli, or with an identical volume of HM buffer (HM).
After the addition of radiolabelled 16/33 precursor protein, the assays were incubated
for 8 min at 25 °C in the light. In the control assay (con), untreated thylakoids resuspended
in HM buffer were used. (C) The proportion of protease-sensitive mOEC33 is independent
of the protease used. Thylakoid transport of the 16/33 chimera was carried out as in (A),
except that post-transport protease treatment was independently performed with either
thermolysin (200 μg/ml), proteinase K (50 μg/ml) or trypsin (3 μg/ml). In lanes t+, 1 μl
of the corresponding protease-treated in vitro translation assay was loaded. The asterisk
marks a trypsin-resistant fragment of the 16/33 translation product. The relative amount
of protease-protected mOEC33 accumulating after transport was calculated in terms
of percentage of total translocated protein in the corresponding assay (mOEC33
in lanes −) and is given below the lanes.
Fig. 2. Structure of the 16/33 chimera and its derivatives. (A) Schematic representation of the 16/33 chimera, the TPP recognition site mutant (16[tpp]/33), and various C-terminally
truncated 16/33 derivatives (16/33[.....stop]). The transit peptide of OEC16 is indicated by white boxes, the respective passenger polypeptides by striped boxes, and the TPP cleavage site
by ﬁlled arrowheads. The sequence of the authentic (VLA) and mutant (VLL) recognition sites for TPP are given in the one-letter-code. (B) Representation of the amino acid sequence of
the 16/33 chimera given in the one-letter-code as deduced from the corresponding cDNA sequences from spinach [38,68,69]. The twin pair of arginine residues indicative for Tat transport
signals is emphasised by two asterisks, the putative Sec-avoidance motif found in the C-terminal region of the OEC16 transit peptide by a single asterisk. The numbering refers to the amino
acid position within the mOEC33 passenger protein. The position of the cysteine, serine, and valine residues used for mutagenesis, which are additionally highlighted in bold, are shown
on top of the respective residue. Likewise in bold are given the ﬁve methionine residues within the transit peptide as well as the single methionine in the passenger protein.
The ﬁlled arrowhead indicates the TPP cleavage site, while the open arrowhead indicates the cleavage site for thermolysin determining the C-terminal border of the 15 kDa fragment.
The residues included in the protease-protected 15 kDa fragment are underscored with a solid line, while additional protease-protected amino acid residues obtained with the mutant
16[tpp]/33 are underscored with a dashed line. Residues 167 to 186, which are required for membrane arrest, are shaded.
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chimera, it was necessary though to ﬁrst replace the two native cysteine
residues at positions 28 and 51 within the mOEC33 passenger protein
(Fig. 2B) by serine residues. Thylakoid transport experiments
performed with the resulting double mutant 16/33[C28S,C51S] (named
C28S,C51S) as well as with either of the corresponding single mutants
C28S and C51S (=16/33[C28S] and 16/33[C51S], respectively) demon-
strate that neither of these substitutions alters the transport properties
of the 16/33 chimera in a qualitative manner. In all thermolysin-
treated thylakoid fractions both mOEC33 and the characteristic 15 kDaFig. 3. The protease-protected fragment does not represent a translocation intermediate.
(A) In thylakoido time-course experiment with the 16/33 precursor protein. The
incubation times are given on top of the lanes. (B) An aliquot of the 5 min assay (con)
shown in (A) was washed with HM buffer, resuspended in HM buffer supplemented
with anti-TatA antibodies, and further incubated in a chase reaction at 25 °C in the dark
for the time periods indicated on top of the lanes (chase). For further details, see the legend
to Fig. 1.fragment can be detected (Fig. 5A). The ratio of protease-sensitive vs.
protease-protected mOEC33, however, is higher for the mutants than
for the “original” 16/33 chimera.
Next, the serine residues at positions 135, 142, 149, and 164 within
the passenger protein of the C28S,C51S double mutant were individual-
ly replaced by cysteine residues and the resulting precursor proteins
(named S135C, S142C, S149C, and S164C, respectively, Fig. 2B) were
subjected to thylakoid transport experiments. In order to take any
potential inﬂuence of the amino acid substitutions on the transport
process into account, the experiments were performed in parallel with
mutant proteins labelledwith either [35S]-methionine or [35S]-cysteine.
In all instances, the accumulation of mOEC33 in the thylakoids can
be observed demonstrating that the mutant precursor proteins are
transported across the thylakoid membrane and processed by TPP.
With mutant S135C also the characteristic 15 kDa fragment is found
in thermolysin-treated thylakoids irrespective of whether the precursor
was labelled with [35S]-cysteine or [35S]-methionine (Fig. 5B) which
proves that residue 135 of mOEC33 is located within the protease-
protected fragment. In contrast, after thylakoid transport of mutants
S149C and S164C the 15 kDa fragment can only be observed for
those proteins labelled with [35S]-methionine, whereas no such
protease-protected fragment can be detected with the corresponding
[35S]-cysteine-labelled precursors. Thus, residues 149 and 164 of the
membrane-embeddedmOEC33moiety remain accessible to proteolysis
from the stromal side of the thylakoid membrane.
Intriguingly, mutant S142C does not unambiguously show the
accumulation of the indicative protease-protected fragment, irrespec-
tive if labelling was performed with [35S]-cysteine or [35S]-methionine.
Instead, only diffuse and/or slightly larger bands are usually observed in
this region of the gel (Fig. 5B and data not shown) suggesting that the
mutated residue is in close proximity to the thermolysin cleavage site
responsible for the generation of the 15 kDa fragment which in turn is
affected by the mutation. Indeed, if thermolysin is replaced by either
proteinase K or trypsin, which have cleavage sites different from those
of thermolysin, the accumulation of the indicative protease-protected
fragments is not impaired (Fig. S2). A thermolysin cleavage site in the
immediate vicinity of the S142C mutation is found upstream of the
phenylalanine residue at position 141 of mOEC33 (Fig. 2B). To check if
this cleavage site determines the C-terminal border of the protease-
protected 15 kDa fragment, a C-terminally truncated 16/33 chimera
was generated in which the codon for F141 is replaced by a stop
codon (Fig. 2A). Thylakoid transport of the resulting 16/33[F141stop]
mutant leads to the accumulation of a protease-resistant processing
product in the thylakoids that upon SDS-PAGE shows comigration
with the protease-protected 15 kDa fragment obtained after thylakoid
transport of the full-size 16/33 precursor (Fig. 6). This result strongly
Fig. 4. In thylakoido transport of the 16[tpp]/33 mutant leads to larger protease-protected fragments. (A) Thylakoid transport of the precursor proteins 16/33 and 16[tpp]/33 was carried
out as in Fig. 1A. The positions of the precursor proteins (p) are indicated by ﬁlled arrowheads, as are those of the corresponding mature protein (m) and protease-protected 30 kDa frag-
ment obtained with the precursor proteins 16/33 and 16[tpp]/33, respectively. Open arrowheads point to the positions of the corresponding membrane-embedded, protease-protected
fragments f and 18 kDa, respectively. For further details, see the legends to Figs. 1 and 2. (B) Schematic representation of the topologies of the precursor proteins 16/33 and 16[tpp]/33
after thylakoid transport. Both complete membrane translocation (left panel) andmembrane arrest (right panel) are shown. The integral Tat translocase (Tat) and the lumenal TPP activity
(arrows) are indicated. Blocked arrows illustrate lack of TPP cleavage in the 16[tpp]/33 mutant. The precursor proteins comprising the Tat-speciﬁc signal peptide with the characteristic
twin-arginine motif (RR) and the central hydrophobic domain (open box) are depicted by bold lines, which are given in black if protected against and in grey if accessible to protease
added from the stromal side to the thylakoids. The apparent molecular weight of each protease-protected protein or fragment is noted in the bottom line. See text for further details.
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membrane-embedded fragment of mOEC33.
3.4. Arrest in membrane translocation is apparently supported by a
hydrophilic protein segment
Such deﬁned arrest of a polypeptide duringmembrane translocation
is reminiscent of the “stop-transfer” phenomenon observed for example
during organelle import of subunit Va of cytochrome c oxidase from
mitochondrial inner membranes [47,48]. In this case, the translocationFig. 5. Fine mapping of the protease-protected 15 kDa fragment. (A) In thylakoido transport o
protease-protected mOEC33 and 15 kDa fragment accumulating after transport, which are gi
in the respective assay (mOEC33 in lanes−). (B) In thylakoido transport of the 16/33 derivative
(35S-Met) or [35S]-cysteine (35S-Cys). The asterisksmark a globin band that is unspeciﬁcally labprocess is interrupted by a hydrophobic domain present within the
translocated polypeptide chain that gets stuck within the translocase
and induces lateral release of the protein into the lipid phase where it
ﬁnally provides membrane anchor function. Remarkably, even “partial”
membrane arrest, i.e. both membrane insertion and translocation of
the same protein domain in a single assay, has been observed before.
The two topologically different isoforms of mitochondrial Mgm1 from
yeast were shown to be the result of either stop-transfer or complete
membrane translocation of an N-terminal membrane anchor domain
of moderate hydrophobicity [49]. AlthoughmOEC33 does not comprisef the cysteine substitution mutants C28S, C51S, and C28S,C51S. The relative amounts of
ven below the lanes, were calculated in terms of percentage of total translocated protein
s S135C, S142C, S149C, and S164C, which were radiolabelled with either [35S]-methionine
elled by [35S]-cysteine. For further details, see the legends to Figs. 1 and 2.
Fig. 6. Comigration of the protease-protected 15 kDa fragmentwith a truncated processing
product. In thylakoido transport of the precursor proteins 16/33 and 16/33[F141stop] was
carried out as in Fig. 1A. For further details, see the legends to Figs. 1 and 2.
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of hydrophobicity within the presumed membrane-spanning protein
segment (Fig. S3), we wanted to investigate if this region of the
passenger polypeptide is able to execute a comparable “stop-transfer”
function. For this purpose, two truncation derivatives of the 16/33 chi-
mera (16/33[L146stop] and 16/33[Y167stop], Fig. 2A), which extend
the C-terminal border of the 15 kDa fragment by 5 and 26 residues,
respectively, were analysed with in thylakoido transport experiments.
Remarkably, in neither case any arrest of membrane translocation
could be observed. Instead, both proteins are completely translocated
across the thylakoidmembrane and processed by TPP to single products
of 16 and 18 kDa, respectively, which are resistant to externally added
protease (Fig. 7). In contrast, thylakoid transport of a 16/33 truncation
mutant with a further C-terminal extension of 20 residues (16/33
[E187stop], Fig. 2A) leads again to two translocation products, the
fully translocated “mature” protein of approximately 20 kDa as well as
the membrane-arrested passenger polypeptide that is represented by
the protease-protected 15 kDa fragment after thermolysin treatment
(Fig. 7). Hence, this additional peptide of 20 amino acids, which
comprises numerous charged residues and is thus remarkably hydro-
philic (Figs. 2B and S3), appears to be required for the observed “stop-Fig. 7. Translocation arrest of 16/33 truncation derivatives. In thylakoido transport of the C-
terminal truncation derivatives L146stop, Y167stop, E187stop, K207stop, and L227stop.
Filled arrowheads on the left hand side of each panel indicate the respective precursor
protein (p), whereas on the right hand side they show the position of the corresponding
processing product (m). Open arrowheads point to the protease-protected 15 kDa
fragment (f). The dashed reference line illustrating the smile effect of the presented gel aligns
corresponding products of identical size in the different in vitro translation assays (marked
with an asterisk) in order to substantiate the conservation of the size of the protease-
protected fragments in the various assays. For further details, see the legends to Figs. 1 and 2.transfer” function, possibly in combinationwith themildly hydrophobic
protein segment. In line with that, any further extension of the C-
terminus up to the entire mOEC33 passenger polypeptide (Fig. 2A)
leads always to two end products after thylakoid transport, fully
translocated “mature” protein as well as membrane-arrested passenger
polypeptide with conserved topology (Fig. 7).
4. Discussion
It was the goal of this study to ﬁnd out what happens if a genuine
passenger protein of the Sec pathway, namely the mature 33 kDa
subunit of the oxygen-evolving system (mOEC33), is compelled into
the Tat pathway operating at the thylakoidmembrane. For this purpose,
mOEC33 was combined with the Tat-speciﬁc transport signal of OEC16
and analysed with in thylakoido protein transport experiments.
4.1. The passenger protein mOEC33 accumulates in two different topologies
in the thylakoids
The Tat pathway is distinguished by its competence to transport
fully folded proteins across themembrane [3,12,13,15], whereas almost
all other membrane transport pathways translocate polypeptides
exclusively in an unfolded conformation. In Escherichia coli, folding
of the passenger protein is even assumed to be a prerequisite for Tat-
dependent membrane translocation [20–22]. This does not strictly
apply though for thylakoidal Tat translocase because a Sec passenger
like mOEC33, which in combination with its authentic transport signal
is presumably translocated as an unfolded polypeptide chain across
the thylakoidmembrane, is in principle suited also formembrane trans-
port by the Tat pathway, as demonstrated by the accumulation of
protease-protected mOEC33 after in thylakoido transport of the 16/33
chimera (Fig. 1B). However, only a subset of the 16/33 molecules is in
fact completely translocated across themembrane in such experiments.
A second, and usually even slightly larger fraction is instead arrested
within the membrane in an N-in/C-out topology (Figs. 1C and 4). Such
premature abortion of membrane translocation of a subset of precursor
molecules, which yields two topologically different end products, differs
from the temporary accumulation of translocation intermediates
like those observed during Tat-dependent membrane transport of the
16/23 chimera (e.g., [33,39,45]).
4.2. How is the membrane-arrest of the mOEC33 passenger
protein provoked?
Oneparameter that apparently determines the success ofmembrane
translocation is the length of the passenger polypeptide chain because
transport abortion is not observed for those 16/33 derivatives compris-
ing passenger polypeptides of less than 167 residues (Fig. 7). Likewise,
plastocyanin, another substrate of the thylakoidal Sec pathway
with a mature size of only 99 amino acid residues [50], does not show
any arrest inmembrane translocation if it is transported by the Tat path-
way across the thylakoid membrane [44,51]. In contrast, all 16/33
derivatives comprising passenger polypeptides of 186 residues or
more show considerable degrees of transport abortion (Fig. 7).
Protein size cannot be the only determinant though, since even
larger proteins than mOEC33 are transported by the Tat pathway with-
out detectablemembrane arrest. However, these passenger proteins are
either authentic Tat substrates and thus presumably folded or have a
strong tendency to fold spontaneously, like for example green ﬂuores-
cent protein [52,53]. This suggests that also the conformation of the
passenger protein plays an important role in the transport process.
Indeed, mutations with the potential to affect the conformation
of mOEC33, like V235P and V240P (Fig. 2B), which introduce a
perturbing proline residue (e.g., [54,55]) into a conserved β-strand,
as deduced from the X-ray structure of the corresponding protein
from Thermosynechococcus elongatus [56], show a greater proportion
452 J. Dittmar et al. / Biochimica et Biophysica Acta 1843 (2014) 446–453of membrane-arrested mOEC33 than the “original” 16/33 chimera
(Fig. S4). A similar result is obtained when the two cysteine residues
at positions 28 and 51, which form a stabilising disulphide bond within
the native protein [56,57], are replaced by serine residues. Despite
the fact that both residues are located in the N-terminal region of the
passenger protein, which even in the membrane-arrested moiety of
mOEC33 was translocated across the membrane, both Cys substitution
mutants show higher levels of transport abortion (Fig. 5A). Hence,
it appears that the conformation of the entire passenger protein has
an inﬂuence on the efﬁciency of its membrane transport by the Tat
pathway.
This suggests that in the 16/33 chimera the passenger protein is at
least partially folded after in vitro translation, in line with earlier obser-
vationsmade for differentmodel proteins [58,59]. Indeed, trypsin treat-
ment of the 16/33 translation product yields a protease-protected
fragment of approximately 24 kDa which can be taken as an indication
for folding (Fig. 1C). Such folding of a Sec passenger in combinationwith
a Tat transport signalwas described also forMalE, a genuine substrate of
E. coli Sec translocase. When synthesised in the bacteria as a precursor
polypeptide with its authentic signal peptide, MalE is prevented from
folding in the cytosol facilitating its transport by the Sec pathway across
the plasmamembrane. However, if synthesised as a chimeric precursor
fused to the Tat-speciﬁc signal peptide of TorA, folding in the bacterial
cytosol is achieved and, consequently, Tat transport of MalE can occur
[60–63].
The inﬂuence of size and/or conformation of a passenger protein
on the efﬁciency of its Tat-dependent membrane translocation has
been observed also in several other studies [31,64–66]. A further feature
inﬂuencing Tat-dependent membrane transport, which has not yet
been described though, is provided by residues 167–186 of the
mOEC33 passenger protein. This exceptionally hydrophilic protein seg-
ment (Fig. S3), which comprises numerous charged residues (Fig. 2B),
is apparently critical for the observed membrane arrest of mOEC33
(Fig. 7), although it is well possible that the mildly hydrophobic seg-
ment upstream of residue 141 is additionally required to accomplish
translocation arrest. Yet, the inﬂuence of the hydrophilic residues
167–186 on the translocation process must be different from that
described by Richter et al. [67] who instead observed a complete block
in Tat-dependent membrane translocation caused by the exposure
of a patch of hydrophobic residues within an unfolded region of the
passenger protein.4.3. Complete Tat transport of the Sec passenger mOEC33 is
difﬁcult to inhibit
Irrespective of the actual mechanism of membrane arrest, it appears
even more remarkable that we could never observe complete abortion
of membrane translocation for any of the 16/33 derivatives. Even
those mutants showing increased membrane arrest accumulate still
considerable amounts of protease-protected mOEC33 in the thylakoids
after transport (Figs. 5A, S4, and data not shown). Hence, despite
potentially destabilising mutations and the presence of putative
transport arrestingprotein segments completemembrane translocation
of the mOEC33 passenger can take place. This demonstrates that
thylakoidal Tat translocase is remarkably ﬂexible with respect to
the conformation of the passenger protein.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2013.11.025.Acknowledgements
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